PharmaDispatch - BioPharmaDispatch

Latest News
COVID-19: Investor scrutiny moves to companies and their executives

The biopharmaceutical sector faces significant scrutiny over the commercialisation and pricing of any COVID-19 vaccine or treatment but investors are also watching companies and their executives.

Latest News Prospection: Call for action on linked datasets May 29, 2020
A new discussion paper from data analytics firm Prospection says the COVID-19 pandemic has highlighted the importance of timely access to linked datasets.
Latest News Flu vax: Telehealth is good, but it's not that good May 29, 2020
"As useful as telehealth can be for delivery of care – not even the best GP can offer a vaccination over the phone or video conference," said Anthony Tassone, Pharmacy Guild Victorian Branch president and national councillor.
Latest News Moving one step close to a patent notification system May 28, 2020
It may have taken 15 years but the Australian government may be moving to at least give the appearance of going closer to implementing a key commitment it made on pharmaceutical patents in the US-Australia FTA.
Latest News COVID-19: Novartis extends support to partner patient groups May 28, 2020
Novartis Australia has announced a special program under which it is extending support to at least 15 partner patient organisations in response to COVID-19.
Latest News AZ's Forxiga secures key CV approval May 28, 2020
AstraZeneca has welcomed an extension to the registration of PBS-listed diabetes medicine FORXIGA (dapagliflozin).
Latest News COVID-19: MSD enters vaccine race in dramatic style May 28, 2020
MSD has entered the COVID-19 race in dramatic style by announcing plans for two potential vaccines and an antiviral treatment.
Latest News 7CPA imminent with split outcome on sticking points May 27, 2020
The Seventh Community Pharmacy Agreement could be signed in just days with the government deciding not to proceed with the 60-day dispensing proposal but sticking with the $1 PBS co-payment discount.
Latest News Medicines NZ moves for change in new action plan May 27, 2020
Medicines New Zealand says patient access to medicines has continued to fall behind comparable countries because its existing medicines action plan has failed to address real issues like funding, equity and scientific advances.
Latest News Official PBS statistics start to reveal impact of COVID-19 May 27, 2020
The official PBS statistics for April 2020 has revealed more on the early impact of the COVID-19 pandemic.
Latest News Tylenol approved for Australian patients May 27, 2020
TGA has approved one of the world's most popular brands of paracetamol under special arrangements introduced to address the risk to patients of medicines shortages.
Latest News WHO halts key COVID-19 trial in response to safety concerns May 27, 2020
The drug, which is used for conditions like Lupus and rheumatoid arthritis, was initially hailed as a treatment for symptoms associated with the COVID-19 virus.

News of the Day

Latest Video

Most Read

New Stories